These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 22928733)
61. Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors. Avvaru BS; Wagner JM; Maresca A; Scozzafava A; Robbins AH; Supuran CT; McKenna R Bioorg Med Chem Lett; 2010 Aug; 20(15):4376-81. PubMed ID: 20605094 [TBL] [Abstract][Full Text] [Related]
62. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. Masereel B; Rolin S; Abbate F; Scozzafava A; Supuran CT J Med Chem; 2002 Jan; 45(2):312-20. PubMed ID: 11784136 [TBL] [Abstract][Full Text] [Related]
63. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides. Mete E; Comez B; Inci Gul H; Gulcin I; Supuran CT J Enzyme Inhib Med Chem; 2016; 31(sup2):1-5. PubMed ID: 27435177 [TBL] [Abstract][Full Text] [Related]
64. Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity. Kumar R; Sharma V; Bua S; Supuran CT; Sharma PK J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1187-1194. PubMed ID: 28891338 [TBL] [Abstract][Full Text] [Related]
65. Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors. Vats L; Kumar R; Bua S; Nocentini A; Gratteri P; Supuran CT; Sharma PK Eur J Med Chem; 2019 Dec; 183():111698. PubMed ID: 31539777 [TBL] [Abstract][Full Text] [Related]
66. A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation. Wang Y; Guo H; Tang G; He Q; Zhang Y; Hu Y; Wang Y; Lin Z Comput Biol Chem; 2019 Jun; 80():234-243. PubMed ID: 31009872 [TBL] [Abstract][Full Text] [Related]
67. Proton transfer and drug binding details revealed in neutron diffraction studies of wild-type and drug resistant HIV-1 protease. Kovalevsky A; Gerlits O; Beltran K; Weiss KL; Keen DA; Blakeley MP; Louis JM; Weber IT Methods Enzymol; 2020; 634():257-279. PubMed ID: 32093836 [TBL] [Abstract][Full Text] [Related]
68. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a bis-sulfonamide-two heads are better than one? Casini A; Abbate F; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2003 Aug; 13(16):2759-63. PubMed ID: 12873509 [TBL] [Abstract][Full Text] [Related]
69. Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors. Korkmaz N; Obaidi OA; Senturk M; Astley D; Ekinci D; Supuran CT J Enzyme Inhib Med Chem; 2015 Feb; 30(1):75-80. PubMed ID: 24666304 [TBL] [Abstract][Full Text] [Related]
70. Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors. Di Fiore A; Pedone C; Antel J; Waldeck H; Witte A; Wurl M; Scozzafava A; Supuran CT; De Simone G Bioorg Med Chem Lett; 2008 Apr; 18(8):2669-74. PubMed ID: 18359629 [TBL] [Abstract][Full Text] [Related]
71. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the perfluorobenzoyl analogue of methazolamide. Implications for the drug design of fluorinated inhibitors. Abbate F; Casini A; Scozzafava A; Supuran CT J Enzyme Inhib Med Chem; 2003 Aug; 18(4):303-8. PubMed ID: 14567544 [TBL] [Abstract][Full Text] [Related]
72. Atomic resolution studies of carbonic anhydrase II. Behnke CA; Le Trong I; Godden JW; Merritt EA; Teller DC; Bajorath J; Stenkamp RE Acta Crystallogr D Biol Crystallogr; 2010 May; 66(Pt 5):616-27. PubMed ID: 20445237 [TBL] [Abstract][Full Text] [Related]
73. Intramolecular proton shuttle supports not only catalytic but also noncatalytic function of carbonic anhydrase II. Becker HM; Klier M; Schüler C; McKenna R; Deitmer JW Proc Natl Acad Sci U S A; 2011 Feb; 108(7):3071-6. PubMed ID: 21282642 [TBL] [Abstract][Full Text] [Related]
74. Synthesis, characterization and in vitro inhibition of metal complexes of pyrazole based sulfonamide on human erythrocyte carbonic anhydrase isozymes I and II. Büyükkıdan N; Büyükkıdan B; Bülbül M; Kasımoğulları R; Mert S J Enzyme Inhib Med Chem; 2017 Dec; 32(1):208-213. PubMed ID: 28114829 [TBL] [Abstract][Full Text] [Related]
75. The effects of some bromophenols on human carbonic anhydrase isoenzymes. Taslimi P; Gülçin İ; Öztaşkın N; Çetinkaya Y; Göksu S; Alwasel SH; Supuran CT J Enzyme Inhib Med Chem; 2016 Aug; 31(4):603-7. PubMed ID: 26133541 [TBL] [Abstract][Full Text] [Related]
76. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. Temperini C; Scozzafava A; Puccetti L; Supuran CT Bioorg Med Chem Lett; 2005 Dec; 15(23):5136-41. PubMed ID: 16214338 [TBL] [Abstract][Full Text] [Related]
77. Synthesis and characterization of some new pyrazolines and their inhibitory potencies against carbonic anhydrases. Çelik G; Arslan T; Şentürk M; Ekinci D Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900292. PubMed ID: 31922298 [TBL] [Abstract][Full Text] [Related]
78. Structure and catalysis by carbonic anhydrase II: role of active-site tryptophan 5. Mikulski R; Domsic JF; Ling G; Tu C; Robbins AH; Silverman DN; McKenna R Arch Biochem Biophys; 2011 Dec; 516(2):97-102. PubMed ID: 22001224 [TBL] [Abstract][Full Text] [Related]
79. A versatile polypeptide platform for integrated recognition and reporting: affinity arrays for protein-ligand interaction analysis. Enander K; Dolphin GT; Liedberg B; Lundström I; Baltzer L Chemistry; 2004 May; 10(10):2375-85. PubMed ID: 15146511 [TBL] [Abstract][Full Text] [Related]
80. Unfolding a folding disease: folding, misfolding and aggregation of the marble brain syndrome-associated mutant H107Y of human carbonic anhydrase II. Almstedt K; Lundqvist M; Carlsson J; Karlsson M; Persson B; Jonsson BH; Carlsson U; Hammarström P J Mol Biol; 2004 Sep; 342(2):619-33. PubMed ID: 15327960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]